FindTrial
Sign In

Omega-3 fish fatty acid reduce mortality of sepsis by modulating immunological functions

Omega-3 fish fatty acid reduce mortality of patients with sepsis and intestinal dysfunction by modulating immunological functions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-12002464
Enrollment
Unknown
Registered
2012-08-26
Start date
2012-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Two groups:omega-3 fish fatty acid versus control

Sponsors

Intensive Care Unit, Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age was above eighteen years old; 2. Systemic inflammatory reaction syndrome (SIRS) was caused by severe infection or trauma; 3. The assessment of Marshall Score was more than three; 4. Intestinal dysfunction, and/or abdominal infection, patients who could not intake nutrition via gut and intestine after abdominal or intestinal surgery; 5. Patients took carbopenems initially after they were transported to intensive care unit (ICU).

Exclusion criteria

Exclusion criteria: 1. Disease was as serious as the Marshall Score 20; 2. The basic disease was so severe that it could directly caused death. Those patients who died within 24 hours in ICU, or the ICU stay was less than seven days, or discharged by themselves, or signed the Do Not Resuscitate Paper (DNR) were also excluded.

Design outcomes

Primary

MeasureTime frame
28-day mortality;ICU stay (day);days of mechanical ventilation;—

Countries

China

Contacts

Public ContactChen Huai-Sheng
hisnamecn@yahoo.com.cn+86 13632571854

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026